• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: COVID-19

Vaccines in development for COVID-19

May 5, 2020  

Slide deck: COVID-19 – Epidemiology in Canada (April 21, 2020)

April 21, 2020  

Slide deck: COVID-19 – Epidemiology in Canada (April 14, 2020)

April 14, 2020  

COVID-19 – FDA approves hydroxychloroquine amid controversy

April 9, 2020  

MS and coronavirus have a long history

April 9, 2020  

Slide deck: COVID-19 – Epidemiology in Canada (April 7, 2020)

April 7, 2020  

MS treatment recommendations during COVID-19 pandemic

March 30, 2020  

Slide deck: COVID-19 – Epidemiology in Canada (March 30, 2020)

March 30, 2020  
Previous
4
5
6

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • ECTRIMS update on ofatumumab posted on October 11, 2024
  • Long-acting injectable aripiprazole approved in Canada posted on August 13, 2014
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions